Patent Tracker
Applications for patents related to psychedelics have boomed in recent years. Nonprofits, pharmaceutical companies, startups, and academic institutions are all jockeying to patent specific psychedelic compounds and formulations. To help keep tabs on the status of patent applications as they wind their way through the U.S. Patent and Trademark’s review process, BCSP has collaborated on a patent tracker with Psychedelic Alpha, an independent media outlet, community and consultancy firm in the psychedelic field, and Calyx Law, a patent law boutique focusing on cannabis and psychedelics related IP. Read more about the history and process of psychedelic patents here.
1300 Patents
Psilocybin & Psilocin
Title
Methods of treating disorders with a psilocybin analog
Subject Matter
Methods of treating various diseases, disorders, and conditions, such as depressive disorders (e.g., Major Depressive Disorder (MDD)), substance use disorders, anxiety disorders, eating disorders, pain, and headache disorders via administration of deuterated psilocin and pharmaceutically acceptable salts, polymorphs, or solvates thereof.
Ibogaine
Title
Methods and compositions for preparing and purifying noribogaine
Subject Matter
Methods and compositions for purifying the non-addictive alkaloid noribogaine.
Ibogaine
Title
Compositions for reducing appetite and craving, increasing satiety, enhancing mood, and reducing stress
Subject Matter
Compositions which reduce craving for unhealthy foods, sweetened beverages and confections, nicotine-containing products, or alcohol without causing undesired physical or psychological side effects, while simultaneously enhancing mood and reducing stress.
LSD
Title
Lsd derivatives, synthesis & method for treatment of diseases and disorders
Subject Matter
LSD derivative compounds and polymorphs thereof, methods for their synthesis, compositions and treatment of diseases and disorders are described herein, the compounds having the structure of a disclosed formula.
Ibogaine
Title
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
Subject Matter
Compositions and methods for the treatment of otic diseases or conditions with free-radical modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition.
Owner
University of California; Otonomy
Patent Number
US9,427,472Priority Date
07.21.2008
Status
Granted
Psilocybin & Psilocin
Title
Crystalline psilacetin derivatives
Subject Matter
Crystalline psilacetin derivatives, compositions containing those crystalline derivatives, and methods of treatment using them.
Psilocybin & Psilocin
Title
Compositions And Methods For Modulating Lipid And Steroid Metabolism
Subject Matter
Methods and compositions related to promoting or reducing colonization of spore-forming bacteria in a patient’s gut, comprising administering a serotonin receptor agonist or a selective serotonin reuptake inhibitor, respectively.
Owner
The Regents of the University of California
Patent Number
US12,514,883Priority Date
03.08.2019
Status
Granted
Psilocybin & Psilocin
Title
Crystalline salts of psilocin
Subject Matter
Crystalline salts of psilocin, beneficial and therapeutic uses of the crystalline psilocin salts and of compositions containing the crystalline psilocin salts, and methods of making and characterizing the crystalline psilocin salts.
Ibogaine
Title
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Subject Matter
Pharmaceutical compositions which are particularly suitable for treating Attention Deficit/Hyperactivity Disorder.
Ibogaine
Title
Compositions for labeling nerves and methods of use
Subject Matter
Methods for guiding preservation of neurons or nerves during surgery by administering a fluorescently-labeled peptide that associates with (e.g., specifically binds to) the neurons or nerves. The invention further provides targeting molecules of fluorescently-labeled peptides or aptamers that associate with (e.g., specifically bind to) neurons or nerves and for compositions thereof.
Page 1 of 130